Cargando…
Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
BACKGROUND: It has been reported that triple negative phenotype is characterized by aggressive clinical history in Western breast cancer patients, however its pattern of metastatic spread had never been reported in the Chinese population. Considering racial disparities, we sought to analyze the spre...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760577/ https://www.ncbi.nlm.nih.gov/pubmed/19778431 http://dx.doi.org/10.1186/1471-2407-9-342 |
_version_ | 1782172761703055360 |
---|---|
author | Lin, Yanping Yin, Wenjin Yan, Tingting Zhou, Liheng Di, Genhong Wu, Jiong Shen, Zhenzhou Shao, Zhimin Lu, Jinsong |
author_facet | Lin, Yanping Yin, Wenjin Yan, Tingting Zhou, Liheng Di, Genhong Wu, Jiong Shen, Zhenzhou Shao, Zhimin Lu, Jinsong |
author_sort | Lin, Yanping |
collection | PubMed |
description | BACKGROUND: It has been reported that triple negative phenotype is characterized by aggressive clinical history in Western breast cancer patients, however its pattern of metastatic spread had never been reported in the Chinese population. Considering racial disparities, we sought to analyze the spread pattern for different sites of first recurrence in Chinese triple negative breast cancers. METHODS: A retrospective study of 1662 patients was carried out from a large database of breast cancer patients undergoing surgery between January 1, 2000 and March 31, 2004 at the Cancer Hospital, Fudan University, Shanghai, China. Survival curves were generated using the Kaplan-Meier method and annual relapse hazards were estimated by the hazard function. RESULTS: We found a statistically significant difference in relapse-free survival (RFS) for locoregional and visceral recurrence (P = 0.007 and P = 0.025, respectively) among the triple negative, ERBB2+ and HR+/ERBB2- subgroups in univariate analysis. In the multivariate Cox proportional hazards regression analysis, RFS for either locoregional or visceral relapse in the triple negative category was inferior to that in HR+/ERBB2- patients (P = 0.027 and P = 0.005, respectively), but comparable to that in ERBB2+ women (both P >0.05). Furthermore, the early relapse peak appeared later in the triple negative group than that in the ERBB2+ counterpart for both locoregional and visceral relapse. On the other hand, when compared with triple negative breast cancers, a significantly lower risk of developing bone relapse was discerned for ERBB2+ women (P = 0.048; HR = 0.384, 95% CI 0.148-0.991), with the borderline significance for HR+/ERBB2- breast cancers (P = 0.058; HR = 0.479, 95% CI 0.224-1.025). In terms of bone metastasis, the hazard rate remained higher for the triple negative category than that for the ERBB2+ subtype. CONCLUSION: Based on the site-specific spread pattern in different subgroups, the triple negative category of breast cancers in the Chinese population exhibits a different pattern of relapse, which indicates that different organotropism may be due to the different intrinsic subtypes. A better knowledge of the triple negative category is warranted for efficacious systemic regimens to decrease and/or delay the relapse hazard. |
format | Text |
id | pubmed-2760577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27605772009-10-13 Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients Lin, Yanping Yin, Wenjin Yan, Tingting Zhou, Liheng Di, Genhong Wu, Jiong Shen, Zhenzhou Shao, Zhimin Lu, Jinsong BMC Cancer Research Article BACKGROUND: It has been reported that triple negative phenotype is characterized by aggressive clinical history in Western breast cancer patients, however its pattern of metastatic spread had never been reported in the Chinese population. Considering racial disparities, we sought to analyze the spread pattern for different sites of first recurrence in Chinese triple negative breast cancers. METHODS: A retrospective study of 1662 patients was carried out from a large database of breast cancer patients undergoing surgery between January 1, 2000 and March 31, 2004 at the Cancer Hospital, Fudan University, Shanghai, China. Survival curves were generated using the Kaplan-Meier method and annual relapse hazards were estimated by the hazard function. RESULTS: We found a statistically significant difference in relapse-free survival (RFS) for locoregional and visceral recurrence (P = 0.007 and P = 0.025, respectively) among the triple negative, ERBB2+ and HR+/ERBB2- subgroups in univariate analysis. In the multivariate Cox proportional hazards regression analysis, RFS for either locoregional or visceral relapse in the triple negative category was inferior to that in HR+/ERBB2- patients (P = 0.027 and P = 0.005, respectively), but comparable to that in ERBB2+ women (both P >0.05). Furthermore, the early relapse peak appeared later in the triple negative group than that in the ERBB2+ counterpart for both locoregional and visceral relapse. On the other hand, when compared with triple negative breast cancers, a significantly lower risk of developing bone relapse was discerned for ERBB2+ women (P = 0.048; HR = 0.384, 95% CI 0.148-0.991), with the borderline significance for HR+/ERBB2- breast cancers (P = 0.058; HR = 0.479, 95% CI 0.224-1.025). In terms of bone metastasis, the hazard rate remained higher for the triple negative category than that for the ERBB2+ subtype. CONCLUSION: Based on the site-specific spread pattern in different subgroups, the triple negative category of breast cancers in the Chinese population exhibits a different pattern of relapse, which indicates that different organotropism may be due to the different intrinsic subtypes. A better knowledge of the triple negative category is warranted for efficacious systemic regimens to decrease and/or delay the relapse hazard. BioMed Central 2009-09-24 /pmc/articles/PMC2760577/ /pubmed/19778431 http://dx.doi.org/10.1186/1471-2407-9-342 Text en Copyright ©2009 Lin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lin, Yanping Yin, Wenjin Yan, Tingting Zhou, Liheng Di, Genhong Wu, Jiong Shen, Zhenzhou Shao, Zhimin Lu, Jinsong Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients |
title | Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients |
title_full | Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients |
title_fullStr | Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients |
title_full_unstemmed | Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients |
title_short | Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients |
title_sort | site-specific relapse pattern of the triple negative tumors in chinese breast cancer patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760577/ https://www.ncbi.nlm.nih.gov/pubmed/19778431 http://dx.doi.org/10.1186/1471-2407-9-342 |
work_keys_str_mv | AT linyanping sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients AT yinwenjin sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients AT yantingting sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients AT zhouliheng sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients AT digenhong sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients AT wujiong sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients AT shenzhenzhou sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients AT shaozhimin sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients AT lujinsong sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients |